Use of Anti-Infective Agents during Lactation, Part 3: Antivirals, Antifungals, and Urinary Antiseptics

Journal of Human Lactation

Volumn 17, Issue 2, 2001, Pages 160-166

  Mactal Haaf, Christina ^a   Hoffman, Maria ^a   Kuchta, Ann ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Anti infectives; Breastfeeding; Human milk; Lactation

Indexed keywords

ANTIINFECTIVE AGENT; DRUG RESIDUE;

BREAST MILK; CHEMISTRY; FEMALE; HUMAN; LACTATION; METABOLISM; NEWBORN; REVIEW;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; DRUG RESIDUES; FEMALE; HUMANS; INFANT, NEWBORN; LACTATION; MILK, HUMAN;

EID: 0035352325     PISSN: 08903344     EISSN: None     Source Type: Journal    
DOI: 10.1177/089033440101700214     Document Type: Article

References (46)

1. Chin KG, Mactal-Haaf C, McPherson CE. Use of anti-infective agents during lactation, part 1: beta-lactam antibiotics, vancomycin, quinupristin-dalfopristin, and linezolid. J Hum Lact. 2000;16: 352-359.
2. Keating MR. Antiviral agents for non-human immunodeficiency virus infections: symposium on antimicrobial agents, part XV. Mayo Clin Proc. 1999;74:1266-1283.
3. Famvir [package insert]. Philadelphia: SmithKline Beecham; 1999.
4. Lau RJ, Emery MG, Galinsky RE. Unexpected accumulation of acyclovir in breast milk with estimation of infant exposure. Obstet Gynecol. 1987;69:468-471.
5. Meyer LJ, Miranda P, Sheth N, Spruance S. Acyclovir in human breast milk. Am J Obstet Gynecol. 1988;158:586-588.
6. Bork K, Benes P. Concentration and kinetic studies of intravenous acyclovir in serum and breast milk of a patient with eczema hepericum. J Am Acad Dermatol. 1995;32:1053-1055.
7. Takemoto CK, Hodding JH, Kraus DM. Pediatric Dosage Handbook. 6th ed. Cleveland, OH: Lexicomp; 1999.
8. Taddio A, Klein J, Koren G. Acyclovirexcretion in human breast milk. Ann Pharmacother. 1994;28:585-587.
9. American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics. 1994;93: 137-150.
10. American Society of Health-System Pharmacists. Antivirals. In: AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists; 2000:2495-2497.
11. Hale T. Medications and Mothers' Milk. 8th ed. Amarillo, TX: Pharmasoft Medical; 1999.
12. Nora JJ, Nora AH, Way GL. Cardiovascular maldevelopment associated with maternal exposure to amantadine. Lancet. 1975;2:607.
13. Relenza [package insert]. Research Triangle Park, NC: GlaxoWellcome; 2000.
14. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 5th ed. Baltimore, MD: Williams & Wilkins; 1998.
15. Van de Perre P. Postnatal transmission of human immunodeficiency virus type 1: the breast-feeding dilemma. Am J Obstet Gynecol. 1995; 173:483-487.
16. Patel R. Antifungal agents, part I: amphotericin B preparations and flucytosine. Mayo Clin Proc. 1998;73:1205-1225. Symposium on Antimicrobial Agents, Part 3.
17. Parfitt K, ed. Martindale: The Complete Drug Reference. London: Pharmaceutical Press; 1999.
18. Flucytosine [package insert]. Nutley, NJ: Roche; 1998.
19. Griseofulvin [package insert]. Raritan, NJ: Ortho Pharmaceutical Corporation; 1997.
20. Albengres E, Le Louet H, Tillement JP. Systemic antifungal agents: drug interactions of clinical significance. Drug Saf. 1998;2:83-97.
21. McClellan KJ, Wiseman LR, Markham A. Terbinafine: an update of its use in superficial mycoses. Drugs. 1999;58:179-202.
22. Lamisil [package insert]. East Hanover, NJ: Novartis; 1999.
23. Terrell CL. Antifungal agents, part II: the azoles. Mayo Clinic Proc. 1999;74:78-100. Symposium on Antimicrobial Agents, Part 4.
24. Kappe R. Antifungal activity of the new azole UK-109,496 (voriconazole). Mycoses. 1999;42(suppl 2):83-86.
25. Schilling CG, Sea RE, Larson TA. Excretion of fluconazole in human breastmilk. Pharmacotherapy. 1993;13:287. Abstract 130.
26. Force RW. Fluconazole concentrations in breastmilk. Pediatr Infect Dis J. 1995;14:235-236.
27. Debruyne D. Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses. Clin Pharmacokinet. 1997;33:52-77.
28. Zichella. Excretion of itraconazole in human breast milk. Unpublished case report; Janssen Research Foundation; 1990.
29. Force RW, Nahata M. Salivary concentrations of ketoconazole and fluconazole: implications for drug efficacy in oropharyngeal and esophageal candidiasis. Ann Pharmacother. 1995;29:10-15.
30. Moretti ME, Ito S, Koren G. Disposition of maternal ketoconazole in breast milk. Am J Obstet Gynecol. 1995;173:1625-1626.
31. Van Lint J, De Doncker P, Woestenborghs R. Chronic use of 2% ketoconazole shampoo in patients with seborrheic dermatitis and dandruff. Curr Ther Res. 1988;43:43-47.
32. Ene MD, Williamson PJ, Daneshmend TK. Systemic absorption of ketoconazole from vaginal pessaries. Br J Clin Pharmacol. 1984; 17:173-175.
33. Sabo JA, Abdel-Rahman SM. Voriconazole: a new triazole antifungal. Ann Pharmacother. 2000;34:1032-1043.
34. American Society of Health-System Pharmacists. Antivirals. In: AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists; 2000:3159-3193.
35. Ernest JM. Topical antifungal agents. Obstet Gynecol Clin North Am. 1992;19:587-607.
36. Docampo R, Moreno SN. The metabolism and mode of action in gentian violet. Drug Metab Rev. 1990;22:161-178.
37. Gupta AK, Einarson TR, Summerbell RC, Shear NH. An overview of topical antifungal therapy in dermatomycoses: a North American perspective. Drugs. 1998;55:645-674.
38. Wilhelm MP, Edson RS. Antimicrobial agents in urinary tract infections. Mayo Clin Proc. 1987;62:1025-1031.
39. Eichenwald HF. Antimicrobial therapy in infants and children: update 1976-1985 (part II). J Pediatr. 1985;107:337-345.
40. Varsano I, Fischl J, Shochet SB. The excretion of orally ingested nitrofurantoin in human milk. J Pediatr. 1973;82:886-887.
41. Pons G, Rey E, Richard MO, et al. Nitrofurantoin in human milk. Dev Pharmacol Ther. 1990;14:148-152.
42. Hosbach RE, Foster RB. Absence of nitrofurantoin from human milk. JAMA 1967;202:1057.
43. Rehm SJ, McHenry MC. Oral antimicrobial drugs. Med Clin North Am 1983;67:57-98.
44. Allgen LG, Holmberg G, Persson B, Sorbo B. Biological fate of methenamine in man: absorption, renal excretion and passage to umbilical cord blood, amniotic fluid and breast milk. Acta Obstet Gynecol Scand. 1979;58:287-293.
45. Berger H. Excretion of mandelic acid in breast milk. Am J Dis Child. 1941;61:256-261.
46. Patel SS, Balfour JA, Bryson HM. Fosfomycin tromethamine: a review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections. Drugs. 1997;53:637-656.